Target intelligence / Profile preview

Nucleolar protein interacting with the FHA domain of MKI67 pseudogene 9 (NIFKP9)

Target
NIFKP9
Molecular classification
Pseudogene, Long non-coding RNA (potential), Other
01

Overview

NIFKP9, or nucleolar protein interacting with the FHA domain of MKI67 pseudogene 9, is a **pseudogene**—a genomic DNA sequence resembling a gene but typically non-functional due to mutations or truncations. It does not code for a functional protein and is classified as a processed or unprocessed pseudogene depending on its origin. Pseudogenes like NIFKP9 can occasionally be transcribed into RNA and may participate in the regulation of related parental genes by acting as sources of regulatory non-coding RNAs or by modulating microRNA availability, but as of current data, there is no evidence that NIFKP9 encodes a targetable protein, has clear biological functions, or is directly implicated in disease or therapeutic targeting[3][2][4]. **Note:** - NIFKP9 should not be confused with NIFK, the functional parental gene, which is involved in mitosis and cell cycle progression[1]. - As with many pseudogenes, annotation and validation are challenging due to sequence similarity with parental genes, and their biological implications, if any, are often subtle or indirect[2][4].

Other names
MKI67 interacting phosphoprotein pseudogene 9MKI67IPP9nucleolar protein interacting with the FHA domain of MKI67 pseudogene 9NIFKP9
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Nucleolar protein interacting with the FHA domain of MKI67 pseudogene 9 (NIFKP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleolar protein interacting with the FHA domain of MKI67 pseudogene 9 (NIFKP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call